Summit Therapeutics (SMMT) Operating Margin (2022 - 2024)
Summit Therapeutics' Operating Margin history spans 2 years, with the latest figure at 1921.89% for Q2 2024.
- For Q2 2024, Operating Margin changed N/A year-over-year to 1921.89%; the TTM value through Dec 2024 reached 3631.66%, changed N/A, while the annual FY2022 figure was 10225.39%, 546110.0% down from the prior year.
- Operating Margin reached 1921.89% in Q2 2024 per SMMT's latest filing, up from 1358.19% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 1921.89% in Q2 2024 to a low of 7700.0% in Q3 2022.